Medical consequences of acute exposure to high altitude.

dc.contributor.author Hallenborg, C P
dc.date.accessioned 2019-07-02T16:19:13Z
dc.date.available 2019-07-02T16:19:13Z
dc.date.issued 1991-03
dc.description.abstract People who ascend rapidly to altitudes greater than 3,000 meters (10,000 ft) may become ill; rarely, some may die from an inability to adapt to hypoxia. Age, pre-existing cardiopulmonary or hematologic disease, and the rate and degree of ascent are known to limit man's adaptation to high altitudes. Other factors, such as blunted hypoxic respiratory drive and sublinical disease of the pulmonary vascular bed are probably also important. Pre-exposure with acetozolamide (Diamox) helps, but once symptoms of high altitude pulmonary edema (HAPE) occur, supplemental oxygen and rapid descent to lower altitudes are the only known remedies. In view of the steady increase in the number of people who work and play at high altitudes, physicians must understand the pathophysiologic mechanisms involved in order to treat properly and to counsel patients.
dc.identifier.issn 0017-8594
dc.identifier.pubmed 2061035
dc.identifier.uri http://hdl.handle.net/10524/62667
dc.language.iso eng
dc.subject.mesh Altitude Sickness/etiology/prevention & control
dc.subject.mesh Humans
dc.subject.mesh Oxygen/blood
dc.subject.mesh Pulmonary Diffusing Capacity/physiology
dc.subject.mesh Risk Factors
dc.subject.mesh Ventilation-Perfusion Ratio/physiology
dc.title Medical consequences of acute exposure to high altitude.
dc.type Journal Article
dc.type Review
dc.type.dcmi Text
prism.number 3
prism.pagerange 96-9
prism.publicationname Hawaii medical journal
prism.volume 50
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1991-03p96-99.pdf
Size:
382.97 KB
Format:
Adobe Portable Document Format
Description: